SAWAI GROUP HOLDINGS Co., Ltd.

Sawai Group Holdings Co., Ltd. and its subsidiaries research, develop, manufacture, and market generic pharmaceuticals. It offers generic drugs in dosage forms such as tablets, orally disintegrating tablets, capsules, granules, injectables, tapes, ophthalmic and nasal solutions, and syrups, covering therapeutic areas including cardiovascular, gastrointestinal, blood and body fluid, metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital and anal, chemotherapeutic and antineoplastic agents, and respiratory, as well as vitamin preparations. The drugs are sold through distributors, wholesalers, and retailers in Japan and the United States. Founded in 1929, the company is headquartered in Osaka, Japan.